Popular content

Type Title
Story Use a Value-Based Strategy for Biotech Medications F. Randy Vogenberg, RPh, PhD
Story Next Generation Anticoagulants May Push Warfarin to the Wayside Bob Kirsch
Story As Drug Payment Model Changes, Confusion Grows Among Insurers Martin Sipkoff
Story Reinsurers Offer Services To Keep Client Costs Down Bob Carlson
Story Specialty Pharmacy Meets Niche Company Expertise Thomas Morrow, MD
Story Large PBMs Transform Old Business Models Thomas Reinke
Story Is Home Infusion Ready for Prime Time? Tom Reinke
Story CBO Predicts Dramatic Rise In Medicaid Costs webadmin
Story The New Consensus Favoring IOM's Definition of Quality Martin Sipkoff
Story Is Pay for Performance Part of the Cure or the Problem? Martin Sipkoff
Story Comparing the Use of Intravenous Antibiotics Under the Medical Benefit With the Use of Oral Antibiotics Under the Pharmacy Benefit in Treating Skin and Soft Tissue Infections John Barron, PharmD
Story How Medical Directors Survive In a Tough Job Market MargaretAnn Cross
Story HMOs Best Stay Mum Regarding Hospice Care Michael S. Victoroff, M.D.
Story Health care executives most highly compensated webadmin
Story Risk contracts help medical groups’ bottom line webadmin
Story Headlines On Deadline... webadmin
Story Trust Should Be Thrust of Managed Care System John La Puma, M.D.
Story Prototypes offer insight into Medicare costs webadmin
Story Reports Confirm High Value of Step-Therapy Programs Martin Sipkoff
Story Single-Payer Proposition Gets Close Second Look John Carroll
Story Executive Coach Helps Physician Adjust to Life as Medical Director Alan G. Adler, MD, MS
Story Interim Federal High-Risk Groups May Far Exceed $5B Allocation John Carroll
Story Maryland HMOs Sue State Commission Over Charges Levied by Hospitals Patrick Mullen
Story Bad Tiered Formulary Designs Yield Poor Outcomes, High Cost Martin Sipkoff
Story A Conversation with William R. Gold, MD: 'Random Gifts of Information' Should Never be Ignored webadmin
more